![]()
|
Report Date : |
27.09.2007 |
IDENTIFICATION DETAILS
|
Name : |
MEDIPLANTEX
NATIONAL PHARMACEUTICAL JOINT-STOCK COMPANY |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2006 |
|
|
|
|
Date of Incorporation : |
1971 |
|
|
|
|
Legal Form : |
Join Stock Company |
|
|
|
|
Line of Business : |
Trading in pharmaceutical, cosmetic, nutritional foods Trading in materials for pharmaceutical production |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Cler |
|
SUBJECT
IDENTIFICATION & LEGAL FORM |
||||||
|
|
||||||
English Name
|
|
MEDIPLANTEX NATIONAL PHARMACEUTICAL JOINT-STOCK COMPANY
|
||||
|
Vietnamese name |
|
CONG TY CO PHAN DUOC TRUNG UONG MEDIPLANTEX |
||||
|
Trade Name |
|
MEDIPLANTEX., JSC |
||||
|
Type of Business |
|
Join Stock
Company |
||||
|
Founded |
|
1971 |
||||
|
Established Decision |
|
No. 406/QD-TCCB |
||||
|
Issued on |
|
April 22nd 1993 |
||||
|
Issued by |
|
Ministry of Health |
||||
|
Former Business
Registration |
|
No.108216 |
||||
|
Issued on |
|
May 22nd 1993 |
||||
|
Issued by |
|
Hanoi Department of Planning and Investment
|
||||
|
Equitization Decision |
|
No.4410/QD-BYT |
||||
|
Issued on |
|
December 7th, 2004 |
||||
|
Issued by |
|
Ministry of Health |
||||
|
Current Business Registration |
|
No. 0103007436 |
||||
|
Issued on |
|
April 12th, 2005 |
||||
|
Issued by |
|
Hanoi Department
of Planning and Investment |
||||
|
Current Registered Capital |
|
37,991,000,000 VND |
||||
|
Former Registered
Capital |
|
17,000,000,000
VND |
||||
|
Tax Code |
|
0100108430 |
||||
|
Total Employees |
|
600 persons |
||||
|
Qualification |
|
Qualified |
||||
|
|
||||||
|
|
||||||
|
ADDRESS |
||||||
Head Office
|
||||||
|
Address |
|
|
||||
|
Country |
|
|
||||
|
Tel |
|
(84-4) 8643368 / 8643367 / 8643363 |
||||
|
Fax |
|
(84-4) 8641584 |
||||
|
Email |
|
|||||
|
Website |
|
|||||
|
|
||||||
|
|
||||||
|
Address |
|
90A/B57 Ly Thuong Kiet Str, Ward.14, Dist
10, |
||||
|
Country |
|
|
||||
|
Tel |
|
(84-8) 8649948 |
||||
|
Fax |
|
(84-8) 8649949 |
||||
|
|
||||||
|
|
||||||
|
Address |
|
No. 249 Nguyen Du Str., Buon Ma Thuot City,
Dak Lak province |
||||
|
Country |
|
|
||||
|
Tel |
|
(84-50) 856015 |
||||
|
Fax |
|
(84-50) 856015 |
||||
|
|
||||||
|
Thai
Binh Branch |
||||||
|
Address |
|
No. 311 Tran Hung Dao Str, De Tham Ward, |
||||
|
Country |
|
|
||||
|
Tel |
|
(84-36) 845565 |
||||
|
Fax |
|
(84-36) 845565 |
||||
|
|
||||||
|
Vinh
Phuc Branch |
||||||
|
Address |
|
|
||||
|
Country |
|
|
||||
|
Tel |
|
(84-211) 878345 |
||||
|
Fax |
|
(84-211) 878345 |
||||
|
Chief of factory |
|
Mr.HA XUAN SON
|
||||
|
Note: This factory has just inaugurate in July 20th
2007 |
||||||
|
|
||||||
|
|
||||||
|
DIRECTORS |
||||||
|
|
||||||
|
1.
NAME |
|
Mr.
TRAN BINH DUYEN |
||||
|
Position |
|
General Director |
||||
|
Date of birth |
|
March 02nd 1947 |
||||
|
ID No. |
|
011800636 |
||||
|
Issued on |
|
July 23rd 1993 |
||||
|
Issued by |
|
Police of |
||||
|
Resident |
|
No.10, 183 Alley Dang Tien Dong, Trung
Liet Ward, Dong Da Dist., |
||||
|
Nationality |
|
Vietnamese |
||||
|
Contact phone |
|
(84-4) 8643363 |
||||
|
|
||||||
|
2.
NAME |
|
Mrs.
DOAN HONG THUY |
||||
|
Position |
|
Deputy General Director |
||||
|
Contact Address |
|
|
||||
|
Nationality |
|
Vietnamese |
||||
|
Contact phone |
|
(84-4) 8647416 |
||||
|
|
||||||
|
|
||||||
|
BUSINESS NATURE
AND ACTIVITIES |
||||||
|
The subject registered in the following
lines of business: |
||||||
|
-
Trading in pharmaceutical, cosmetic, nutritional
foods -
Trading in materials for pharmaceutical
production -
Import and export service -
Trading medical equipments -
… |
||||||
|
|
||||||
|
|
||||||
|
IMPORT &
EXPORT ACTIVITIES |
||||||
|
|
||||||
|
IMPORT: The subject
imports from |
||||||
|
EXPORT: The subject
exports to |
||||||
|
|
||||||
|
|
||||||
|
BANKERS |
||||||
|
|
||||||
|
1.
BANK FOR FOREIGN TRADE OF |
||||||
|
Address |
|
No. 198 Tran Quang Khai Str., |
||||
|
Tel |
|
(84-4) 824 0976 |
||||
|
Fax No |
|
(84-4) 826 9067 |
||||
|
Account No (USD) |
|
001.1.37.00.77080 |
||||
|
Account No (VND) |
|
001.1.00.00.13526 |
||||
|
Note: The given
address (4749 Ly Thai To, |
||||||
|
|
||||||
|
2.
INDUSTRIAL AND COMMERCIAL BANK OF |
||||||
|
Address |
|
No. 187 Tay Son Str, Dong Da Dist, |
||||
|
Tel |
|
(84-4) 851620 |
||||
|
Account No (USD) |
|
10202.00000.6931 |
||||
|
|
||||||
|
|
||||||
|
SHAREHOLDERS |
||||||
|
|
||||||
1. Name
|
|
VIETNAM PHARMACEUTICAL CORPORATION
|
||||
Address
|
|
No.
138B Giang Vo Str,
|
||||
Tel
|
|
(84-4)
8443153
|
||||
Fax
|
|
(84-4)
8443665
|
||||
Representative
person
|
|
Mr. TRAN BINH DUYEN
|
||||
Resident
|
|
No. 10,
183 Alley Dang Tien Dong, Trung Liet Ward, Dong Da Dist.,
|
||||
|
Share |
|
47,600 shares |
||||
|
|
||||||
3. Name
|
|
663 OTHER
SHAREHOLDERS |
||||
Position
|
|
Shareholder |
||||
|
Share |
|
232,486 shares |
||||
|
|
||||||
|
|
||||||
|
PAYMENT HISTORY
AND EXPERIENCES |
||||||
|
|
||||||
|
Trade Morality |
|
Fairly Good |
||||
|
Liquidity |
|
Average |
||||
|
Payments |
|
Above Average |
||||
|
Financial Situation |
|
Above Average |
||||
|
Development trend |
|
Fairly Good |
||||
|
Litigation Data |
|
No reported |
||||
|
Bankruptcy |
|
No reported |
||||
|
Payment Method |
|
TT, L/C |
||||
|
|
|
Supplying for agents, customers |
||||
|
|
||||||
|
|
||||||
|
FINANCIAL DATA |
||||||
|
BALANCE
SHEET |
||||||
Unit: VND Million
|
||||||
|
Balance sheet
date |
31/12/06 |
31/12/05 |
31/12/04 |
31/12/03 |
||
|
Number of weeks |
52 |
52 |
52 |
52 |
||
ASSETS
|
||||||
|
A.
Working assets & short-term Investment |
239,952 |
252,659 |
211,314 |
174,907 |
||
|
I. Cash and cash equivalents |
9,184 |
7,749 |
6,282 |
3,108 |
||
|
II. Short-term investment |
0 |
0 |
0 |
0 |
||
|
1. Short-term securities
investment |
0 |
0 |
0 |
0 |
||
|
2. Other short-term investment |
0 |
0 |
0 |
0 |
||
|
3. Provision for short-term
investment |
0 |
0 |
0 |
0 |
||
|
III. Receivables |
127,614 |
116,963 |
94,939 |
81,029 |
||
|
1. Receivables from customers |
109,255 |
96,908 |
83,356 |
73,746 |
||
|
2. Prepayment for providers |
8,981 |
6,592 |
9,760 |
6,931 |
||
|
3. Value-added tax deducted |
973 |
2,133 |
1,789 |
786 |
||
|
4. Internal receivables |
0 |
10,851 |
115 |
0 |
||
|
5. Other receivables |
8,405 |
479 |
328 |
0 |
||
|
6. Provision for bad receivables |
0 |
0 |
-409 |
-434 |
||
|
IV. Inventory |
100,081 |
124,160 |
108,196 |
89,260 |
||
|
1.
Purchased goods in transit |
0 |
0 |
0 |
0 |
||
|
2. Raw materials |
0 |
4,347 |
3,840 |
5,991 |
||
|
3. Instrument, tools |
0 |
1,840 |
1,702 |
1,671 |
||
|
4. Cost for production and
business in process |
0 |
620 |
2,290 |
803 |
||
|
5. End products |
0 |
0 |
0 |
0 |
||
|
6. Goods |
100,081 |
117,353 |
100,364 |
80,795 |
||
|
7. Goods on consignment |
0 |
0 |
0 |
0 |
||
|
8. Provision for devaluation of
stocks |
0 |
0 |
0 |
0 |
||
|
V. Other current assets |
3,073 |
789 |
624 |
485 |
||
|
1. Advances |
0 |
519 |
588 |
433 |
||
|
2. Prepaid
expenses |
50 |
0 |
0 |
52 |
||
|
3. Pending expenses for
transfer |
0 |
0 |
0 |
0 |
||
|
4. Tax and accounts receivable to
State budget |
0 |
0 |
0 |
0 |
||
|
5. Other current assets |
3,023 |
270 |
36 |
0 |
||
VI.
Administrative
|
0 |
2,998 |
1,273 |
1,025 |
||
1. Administrative expenses for previous year
|
0 |
2,998 |
0 |
0 |
||
2. Administrative expenses for current year
|
0 |
0 |
1,273 |
1,025 |
||
|
B. Fixed assets
& Long term investment |
59,430 |
16,756 |
11,879 |
11,998 |
||
|
I. Fixed assets |
57,317 |
16,756 |
11,879 |
11,998 |
||
|
1. Tangible fixed assets |
51,712 |
16,756 |
11,879 |
11,998 |
||
|
+ Original cost |
68,306 |
31,686 |
24,902 |
22,504 |
||
|
+ Accumulated depreciation
value |
-16,594 |
-14,930 |
-13,023 |
-10,506 |
||
|
2. Financial leasing fixed
assets |
0 |
0 |
0 |
0 |
||
|
+ Original cost |
0 |
0 |
0 |
0 |
||
|
+ Accumulated depreciation
value |
0 |
0 |
0 |
0 |
||
|
3. Intangible fixed assets |
5,605 |
0 |
0 |
0 |
||
|
+ Original cost |
5,605 |
0 |
0 |
0 |
||
|
+ Accumulated depreciation
value |
0 |
0 |
0 |
0 |
||
|
II. Long term investment |
1,153 |
0 |
0 |
0 |
||
|
1. Long-term securities investment |
0 |
0 |
0 |
0 |
||
|
2. Joint-venture capital contribution |
1153 |
0 |
0 |
0 |
||
|
3. Other long-term investment |
0 |
0 |
0 |
0 |
||
|
4. Provision for long-term investment devaluation |
0 |
0 |
0 |
0 |
||
|
III. Capital construction in process |
0 |
0 |
0 |
0 |
||
|
IV. Other |
960 |
0 |
0 |
0 |
||
|
TOTAL ASSETS |
299,382 |
269,415 |
223,193 |
186,905 |
||
LIABILITIES
|
||||||
|
A.
Payable loans |
242,198 |
242,999 |
200,775 |
168,271 |
||
|
I. Short term payables |
233,632 |
240,826 |
197,802 |
163,822 |
||
|
1. Short-term borrowings |
149,141 |
173,529 |
160,448 |
130,580 |
||
|
2. Due long-term liabilities |
0 |
0 |
0 |
0 |
||
|
3. Payables to supplier |
60,698 |
56,981 |
33,846 |
38,646 |
||
|
4. Prepayment of buyer |
10,553 |
8,495 |
5,976 |
5,958 |
||
|
5. Taxes and accounts dutiable |
1,502 |
-7,024 |
-5,358 |
-11,359 |
||
|
6. Employee payments |
0 |
0 |
12 |
10 |
||
|
7. Internal payables |
0 |
0 |
0 |
0 |
||
|
8. Other payables |
11,738 |
8,845 |
2,878 |
-13 |
||
|
II. Long term loans |
8,566 |
2,173 |
2,973 |
4,449 |
||
|
1. Long-term borrowings |
8,566 |
2,173 |
2,973 |
4,449 |
||
|
2. Long-term payables |
0 |
0 |
0 |
0 |
||
|
III. Other payables |
0 |
0 |
0 |
0 |
||
|
1. Payable expenses |
0 |
0 |
0 |
0 |
||
|
2. Pending assets |
0 |
0 |
0 |
0 |
||
|
3. Receipts long-term collateral and deposit |
0 |
0 |
0 |
0 |
||
|
B. Owner’s
Equity |
57,184 |
26,416 |
22,418 |
18,634 |
||
|
I. Capital and
Funds |
55,670 |
22,409 |
20,287 |
16,923 |
||
|
1. Working capital |
37,683 |
16,692 |
16,693 |
15,886 |
||
|
2. Differences from asset revaluation |
0 |
0 |
0 |
0 |
||
|
3. Exchange rate differences |
0 |
0 |
0 |
0 |
||
|
4. Development investment funds |
310 |
310 |
310 |
0 |
||
|
5. Reserved funds |
8,396 |
0 |
0 |
0 |
||
|
6. Retained profit |
6,521 |
2,593 |
470 |
1,037 |
||
|
7. Construction capital sources |
2,760 |
2,814 |
2,814 |
0 |
||
|
II. Other administrative and fund sources |
1,514 |
4,007 |
2,131 |
1,711 |
||
|
1. Provident funds for unemployment |
0 |
0 |
0 |
0 |
||
|
2. Reward and welfare funds |
288 |
288 |
311 |
125 |
||
|
3. Management funds of higher level |
0 |
0 |
0 |
0 |
||
|
4. Functional operation funds |
978 |
3,399 |
1,820 |
1,586 |
||
|
Current year |
978 |
3,399 |
1,366 |
256 |
||
|
Last year |
0 |
0 |
454 |
1,330 |
||
|
5. Fund sources formed by fixed assets |
248 |
320 |
0 |
0 |
||
|
TOTAL LIABILITY
AND EQUITY |
299,382 |
269,415 |
223,193 |
186,905 |
||
|
|
||||||
|
PROFIT
& LOSE STATEMENT |
||||||
|
|
||||||
|
Description |
FY 2006 |
FY 2005 |
FY 2004
|
FY 2003 |
||
|
Total
revenue |
463,867 |
474,458 |
440,736 |
396,293 |
||
|
Deductions Items |
38 |
33 |
5,023 |
3 |
||
|
- Discount |
- |
0 |
0 |
0 |
||
|
- Devaluation |
- |
0 |
3 |
0 |
||
|
- Return of sold goods |
- |
0 |
4,996 |
3 |
||
|
- Turnover tax, Luxury tax & Export tax |
- |
33 |
24 |
0 |
||
|
1. Net revenue |
463,829 |
474,425 |
435,713 |
396,290 |
||
|
2. Cost of goods sold |
424,793 |
440,755 |
404,576 |
368,485 |
||
|
3. Gross Profit |
39,036 |
33,670 |
31,137 |
27,805 |
||
|
4. Sales expenses |
13,446 |
11,135 |
10,955 |
11,161 |
||
|
5. |
9,567 |
8,923 |
10,453 |
9,655 |
||
|
6. Net income from business activities |
16,023 |
13,612 |
9,729 |
6,989 |
||
|
Income from financial activities |
4,780 |
2,444 |
1,089 |
555 |
||
|
Expenditure from financial activities |
14,821 |
13,901 |
10,148 |
9,497 |
||
|
7. Net income
from financial operation |
-10,041 |
-11,457 |
-9,059 |
-8,942 |
||
|
Irregular income |
361 |
0 |
3 |
2,559 |
||
|
Irregular expenditure |
1,653 |
26 |
15 |
3 |
||
|
8. Irregular
Profit |
-1292 |
-26 |
-12 |
2,556 |
||
|
9.
Total pre-tax profit |
4,690 |
2,129 |
658 |
603 |
||
|
10. Income tax |
0 |
596 |
184 |
193 |
||
|
11.
After tax profit |
4,690 |
1,533 |
474 |
410 |
||
|
|
||||||
|
|
||||||
|
FINANCIAL FACTORS |
||||||
|
|
||||||
|
Description |
FY 06 |
FY 05 |
FY 04 |
FY 03 |
||
|
Current liquidity ratio |
1.03 |
1.05 |
1.07 |
1.07 |
||
|
Quick Liquidity ratio |
0.60 |
0.53 |
0.52 |
0.52 |
||
|
Inventory circle |
4.24 |
3.79 |
4.10 |
8.26 |
||
|
Average receive period |
100.42 |
89.99 |
79.53 |
74.63 |
||
|
Utilizing Asset Performance |
1.55 |
1.76 |
1.95 |
2.12 |
||
|
Liability/ Total Asset (%) |
80.90 |
90.20 |
89.96 |
90.03 |
||
|
Liability/ Owner's equity (%) |
423.54 |
919.89 |
895.60 |
903.03 |
||
|
Income before tax/ Total asset (%) ROA |
1.57 |
0.79 |
0.29 |
0.32 |
||
|
Income before tax/ Owner's equity (%) ROE |
8.20 |
8.06 |
2.94 |
3.24 |
||
|
Gross Profit / Total revenue (%) GPM |
8.42 |
7.10 |
7.06 |
7.02 |
||
|
Income before tax/ Total revenue (%) NPM |
1.01 |
0.45 |
0.15 |
0.15 |
||
|
|
||||||
|
|
||||||
|
INTERPRETATION |
||||||
|
Mediplantex is now a Joint Stock Company. The former type of the subject was a state-owned company, which was established in 1971. The subject has been operated in the fields of plantation, production, and export of various species of material pharmacy from medical plants for many years such as Artemisia annual, Saphora japonica, Peppermint, etc. The subject has business relationship with over 20 foreign partners all over the world. The position in the industry of the subject is good. The subject’s premises are large. The management capability
of the subject is average. The subject now focuses on planting medicinal
plants, processing and export of material for foreign manufacturers. Besides,
the subject is also a large trader in pharmaceutical industry. The subject
imports and trades a large amount of products in Northern region of The turnover of the subject is increasing. Its financial status is normal. The long term loans are still high despite a slightly decrease in 2005 compared with that of 2004. According to the result of audited report, total assets of the subject as of 31/12/2006 was 299,3 billion VND, increased in comparison with the year 2005 of 32,9 billion VND, total revenue was 463,8 billion, gross profit was about 40 billion VND. As for our observation, the business activities of the subject seem to be busier than before. However, like many other state-owned companies, it is not really active and professional in doing business. Its staffs are graded at normal. Nevertheless, the subject will gradually catch up with the changes of globalization with its new form of owner after equitization. Its prospect seems to be bright. In short, the operation and finance are regard good. The business of the subject is stable and development. The subject has capacity to meet the financial commitments. No caution needed for the business transactions. |
||||||
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)